首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Drug utilization study in Pregnancy induced hypertension in a tertiary care teaching hospital
【24h】

Drug utilization study in Pregnancy induced hypertension in a tertiary care teaching hospital

机译:三级教学医院妊娠高血压综合征的药物利用研究

获取原文
           

摘要

Introduction: Pregnancy induced hypertension(PIH) is one of the most common complications of pregnancy worldwide.It is associated with both maternal mortality and morbidity as well as perinatal mortality. Though a number of drugs are available to treat PIH, differences in benefit-risk ratio of these drugs stresses the need for surveying the use of these drugs. Methods: The present study is a retrospective observational study performed on the basis of case record sheets of patients admitted with PIH. Results: Out of the total prescriptions studied the most commonly prescribed antihypertensive was Methyldopa, followed by Labetalol. Nifedipine, Amlodipine, and Magnesium sulphate were the other drugs prescribed. Majority drugs prescribed were from category B and C. Single drug therapy was prescribed in 79.87 % patients. Conclusion: Methyldopa was the commonly prescribed antihypertensive. None of the prescribed drugs were from teratogenic category D and X.
机译:简介:妊高征(PIH)是全球范围内最常见的妊娠并发症之一,它与孕产妇死亡率和发病率以及围产期死亡率有关。尽管有许多药物可用于治疗PIH,但这些药物的受益风险比不同,因此有必要对这些药物的使用进行调查。方法:本研究是一项回顾性观察性研究,其依据是PIH入院患者的病历表。结果:在研究的总处方中,最常用的降压药是甲基多巴,其次是拉贝洛尔。硝苯地平,氨氯地平和硫酸镁是其他处方药。开出的多数药物来自B类和C类。79.87%的患者开出了单药治疗。结论:甲基多巴是常用的降压药。没有处方药来自致畸类别D和X。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号